Annual Cash & Cash Equivalents
$306.95 M
+$159.18 M+107.72%
December 31, 2024
Summary
- As of March 12, 2025, ITCI annual cash & cash equivalents is $306.95 million, with the most recent change of +$159.18 million (+107.72%) on December 31, 2024.
- During the last 3 years, ITCI annual cash & cash equivalents has risen by +$214.58 million (+232.32%).
- ITCI annual cash & cash equivalents is now at all-time high.
Performance
ITCI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$306.95 M
-$157.36 M-33.89%
December 1, 2024
Summary
- As of March 12, 2025, ITCI quarterly cash and cash equivalents is $306.95 million, with the most recent change of -$157.36 million (-33.89%) on December 1, 2024.
- Over the past year, ITCI quarterly cash and cash equivalents has stayed the same.
- ITCI quarterly cash and cash equivalents is now -55.73% below its all-time high of $693.31 million, reached on June 30, 2024.
Performance
ITCI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ITCI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +107.7% | 0.0% |
| 3 y3 years | +232.3% | +208.8% |
| 5 y5 years | +185.2% | +208.8% |
ITCI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +232.3% | -55.7% | +305.3% |
| 5 y | 5-year | at high | +411.2% | -55.7% | +411.2% |
| alltime | all time | at high | >+9999.0% | -55.7% | -100.0% |
Intra-Cellular Therapies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $306.95 M(+107.7%) | - |
| Dec 2024 | - | $306.95 M(-33.9%) |
| Sep 2024 | - | $464.31 M(-33.0%) |
| Jun 2024 | - | $693.31 M(+395.9%) |
| Mar 2024 | - | $139.82 M(-5.4%) |
| Dec 2023 | $147.77 M(-0.6%) | $147.77 M(+48.7%) |
| Sep 2023 | - | $99.40 M(-30.1%) |
| Jun 2023 | - | $142.26 M(+87.9%) |
| Mar 2023 | - | $75.73 M(-49.0%) |
| Dec 2022 | $148.62 M(+60.9%) | $148.62 M(+9.8%) |
| Sep 2022 | - | $135.36 M(+75.3%) |
| Jun 2022 | - | $77.23 M(-40.3%) |
| Mar 2022 | - | $129.29 M(+40.0%) |
| Dec 2021 | $92.36 M(+53.8%) | $92.36 M(-13.0%) |
| Sep 2021 | - | $106.13 M(-12.3%) |
| Jun 2021 | - | $121.03 M(-6.9%) |
| Mar 2021 | - | $129.98 M(+116.5%) |
| Dec 2020 | $60.05 M(-44.2%) | $60.05 M(-80.1%) |
| Sep 2020 | - | $300.99 M(+132.8%) |
| Jun 2020 | - | $129.29 M(-28.0%) |
| Mar 2020 | - | $179.59 M(+66.9%) |
| Dec 2019 | $107.64 M | $107.64 M(+5.4%) |
| Sep 2019 | - | $102.16 M(+11.3%) |
| Jun 2019 | - | $91.76 M(+43.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $64.09 M(+16.6%) |
| Dec 2018 | $54.95 M(+45.4%) | $54.95 M(-21.3%) |
| Sep 2018 | - | $69.78 M(+0.0%) |
| Jun 2018 | - | $69.77 M(-6.3%) |
| Mar 2018 | - | $74.42 M(+96.9%) |
| Dec 2017 | $37.79 M(-22.3%) | $37.79 M(-27.8%) |
| Sep 2017 | - | $52.34 M(+76.9%) |
| Jun 2017 | - | $29.59 M(+25.4%) |
| Mar 2017 | - | $23.60 M(-51.5%) |
| Dec 2016 | $48.64 M(+3.1%) | $48.64 M(-75.7%) |
| Sep 2016 | - | $200.39 M(+285.6%) |
| Jun 2016 | - | $51.97 M(+39.6%) |
| Mar 2016 | - | $37.24 M(-21.0%) |
| Dec 2015 | $47.16 M(-23.1%) | $47.16 M(-85.8%) |
| Sep 2015 | - | $332.83 M(+366.0%) |
| Jun 2015 | - | $71.42 M(-29.1%) |
| Mar 2015 | - | $100.80 M(+64.4%) |
| Dec 2014 | $61.33 M(+74.5%) | $61.33 M(-11.0%) |
| Sep 2014 | - | $68.92 M(-24.4%) |
| Jun 2014 | - | $91.14 M(-36.5%) |
| Mar 2014 | - | $143.62 M(+308.6%) |
| Dec 2013 | $35.15 M(>+9900.0%) | $35.15 M(-20.2%) |
| Sep 2013 | - | $44.07 M(>+9900.0%) |
| Jun 2013 | - | $0.00 |
| Mar 2013 | $4100.00 | - |
FAQ
- What is Intra-Cellular Therapies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual cash & cash equivalents year-on-year change?
- What is Intra-Cellular Therapies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly cash and cash equivalents year-on-year change?
What is Intra-Cellular Therapies annual cash & cash equivalents?
The current annual cash & cash equivalents of ITCI is $306.95 M
What is the all time high annual cash & cash equivalents for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual cash & cash equivalents is $306.95 M
What is Intra-Cellular Therapies annual cash & cash equivalents year-on-year change?
Over the past year, ITCI annual cash & cash equivalents has changed by +$159.18 M (+107.72%)
What is Intra-Cellular Therapies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ITCI is $306.95 M
What is the all time high quarterly cash and cash equivalents for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly cash and cash equivalents is $693.31 M
What is Intra-Cellular Therapies quarterly cash and cash equivalents year-on-year change?
Over the past year, ITCI quarterly cash and cash equivalents has changed by $0.00 (0.00%)